Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) Debt to Equity (2017 - 2019)

Historic Debt to Equity for AC Immune (ACIU) over the last 3 years, with Q4 2019 value amounting to $0.0.

  • AC Immune's Debt to Equity fell 1793.78% to $0.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $0.0, marking a year-over-year decrease of 1793.78%. This contributed to the annual value of $0.0 for FY2019, which is 1793.78% down from last year.
  • AC Immune's Debt to Equity amounted to $0.0 in Q4 2019, which was down 1793.78% from $0.0 recorded in Q4 2018.
  • AC Immune's 5-year Debt to Equity high stood at $0.0 for Q4 2017, and its period low was $0.0 during Q4 2019.
  • In the last 3 years, AC Immune's Debt to Equity had a median value of $0.0 in 2018 and averaged $0.0.
  • Per our database at Business Quant, AC Immune's Debt to Equity plummeted by 3102.5% in 2018 and then plummeted by 1793.78% in 2019.
  • Quarter analysis of 3 years shows AC Immune's Debt to Equity stood at $0.0 in 2017, then plummeted by 31.03% to $0.0 in 2018, then decreased by 17.94% to $0.0 in 2019.
  • Its last three reported values are $0.0 in Q4 2019, $0.0 for Q4 2018, and $0.0 during Q4 2017.